Angela Fedorcuk, DPM | |
970 Hope Street, Suite 6, Bristol, RI 02809-5210 | |
(401) 254-0922 | |
(401) 254-8894 |
Full Name | Angela Fedorcuk |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 970 Hope Street, Bristol, Rhode Island |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467547661 | NPI | - | NPPES |
2700166 | Other | UNITED HEALTHCARE | |
9007059 | Medicaid | RI | |
70599 | Other | RI | BLUE CROSS BLUE SHIELD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213E00000X | Podiatrist | DPM260 (Rhode Island) | Primary |
213E00000X | Podiatrist | 1941 (Massachusetts) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Angela Fedorcuk, DPM 970 Hope Street, Suite 6, Bristol, RI 02809-5210 Ph: (401) 254-0922 | Angela Fedorcuk, DPM 970 Hope Street, Suite 6, Bristol, RI 02809-5210 Ph: (401) 254-0922 |
News Archive
Bisphenol S, a chemical used to manufacture polycarbonate water bottles and many other products such as epoxy glues and cash receipts, is an increasingly common replacement for bisphenol A, the of which was discontinued because of concerns about its harmful effects on the reproductive system.
Based on a survey of parents of children with congenital heart disease, physicians delivering the diagnosis need to do a better job of showing compassion, ensuring parents understand all their options and providing easily understandable information, according to a new study published in the February edition of the journal, Pediatric Cardiology.
Researchers in this PLoS Medicine article examine the efforts necessary to reach the WHO goal of reducing mother-to-child HIV transmission (MTCT) risk to less than five percent in Zimbabwe.
Cancer researchers in Würzburg, in cooperation with the international Cancer Genome Atlas Research Network, have identified new genetic drivers of adrenal cancer. Würzburg was the center of coordination of the European scientists.
St. Jude Medical, Inc., a global medical device company, today announced the publication of results from an economic evaluation of the landmark FAME (Fractional Flow Reserve (FFR) vs. Angiography in Multivessel Evaluation) trial, which confirmed FFR-guided percutaneous coronary intervention (PCI) in patients with multivessel coronary artery disease improves patient outcomes and offers cost-saving benefits to the U.S. healthcare system.
› Verified 5 days ago
Dr. Michael Aaron Reuter, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1180 Hope St, Bristol, RI 02809 Phone: 401-253-8900 | |
Richard Alan Reuter, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 1180 Hope St, Bristol, RI 02809 Phone: 401-253-8900 Fax: 401-253-3131 | |
Jordan Samuel Dehaven, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1180 Hope St, Bristol, RI 02809 Phone: 401-253-8900 Fax: 401-253-3131 |